October 19, 2017 4:15 AM ET


Company Overview of DSM Anti Infectives India Limited

Company Overview

DSM Anti Infectives India Limited manufactures and markets penicillin based drug intermediates and bulk drugs, such as Ampicillin, Amoxycillin, and Cephalexin. The company was formerly known as Max-GB Limited. DSM Anti Infectives India Limited was founded in 1993 and is based in Gurgaon, India. The company operates as a subsidiary of Royal DSM N.V.

DLF Phase-II

Infinity Towers

Tower A

9th Floor

Gurgaon,  122002


Founded in 1993


91 12 4417 9900


91 12 4417 9850

Key Executives for DSM Anti Infectives India Limited

DSM Anti Infectives India Limited does not have any Key Executives recorded.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DSM Anti Infectives India Limited, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.